Description:
Methyl 3-guanidino-4-methylbenzoate mononitrate, a highly versatile pharmaceutical intermediate, is utilized for the synthesis of nitric oxide synthase isoform-specific drugs that exhibit therapeutic potential against a variety of cardiovascular and inflammatory maladies associated with NOS isoform dysregulation. Its wide scope of therapeutic applications underscores its immense potential as a drug precursor.
Molecular Formula:
C10H14N4O5
Canonical SMILES:
CC1=C(C=C(C=C1)C(=O)OC)N=C(N)N.[N+](=O)(O)[O-]
InChI:
InChI=1S/C10H13N3O2.HNO3/c1-6-3-4-7(9(14)15-2)5-8(6)13-10(11)12;2-1(3)4/h3-5H,1-2H3,(H4,11,12,13);(H,2,3,4)
InChIKey:
SFHRCNFZNRMPOT-UHFFFAOYSA-N
Synonyms:
methyl 3-guanidino-4-methylbenzoate nitrate Weitere Informationen finden Sie
hier